LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Launched by DIASORIN MOLECULAR LLC · Apr 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two tests, the LIAISON® NES Flu A/B, RSV & COVID-19 assay and the LIAISON PLEX® RSP Flex assay, to see how accurately they can detect respiratory viruses in people who are showing signs of illness. The trial aims to find out if these tests work well when samples are collected by healthcare professionals or by patients themselves using nasal swabs. It focuses on patients in Australia who have symptoms of respiratory infections, which can include illnesses like the flu or COVID-19.

To participate, individuals need to have symptoms of a respiratory infection and provide samples within a week of when their symptoms started. They also need to give their consent to take part in the study. Participants can expect to undergo testing and may be asked for information about their health history. It's important to note that the trial is not yet recruiting participants, so this is just an early stage in the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Human patients with active signs and symptoms of respiratory tract infection at time of collection
• • Specimens collected within 7 days of symptom onset for the initial collection
• • Patient consents to participate in the study
• • Availability of age, gender, race, ethnicity, collection dates, collection time, routine respiratory testing method, routine respiratory result, signs and symptoms (e.g., fever), date of symptom onset for each symptom, vaccination status (Flu and COVID-19, as applicable), pre-existing medical conditions (as applicable), medications (e.g., COVID-19 antivirals), etc. for each subject
• Exclusion Criteria:
• • Incorrect swab type
• • Incorrect transport media
• • Incorrect specimen handling (specimens not stored at recommended temperature)
• • Samples collected \>7 days from symptom onset
• • Subject does not provide informed consent or subject withdraws informed consent